Risk of parametrial involvement (%) | 95% CI | SLN status | Tumor size | No of total patients | No of patients with parametrial involvement | % of patients with parametrial involvement | |
Low-risk | 0.9 | 0.2 to 4.4 | Negative | <20 mm | 114 | 1 | 0.9 |
Intermediate-risk | 4.6 | 0.5 to 31.5 | ITC | <20 mm | 3 | 0 | 0 |
7.9 | 1.4 to 33.2 | MIC or MAC | <20 mm | 10 | 1 | 10 | |
8.1 | 2.8 to 21.3 | Negative | ≥20 mm | 36 | 3 | 8.3 | |
High-risk | 31.0 | 7.9 to 70.2 | ITC | ≥20 mm | 6 | 2 | 33.3 |
44.3 | 14.6 to 78.6 | MIC or MAC | ≥20 mm | 5 | 2 | 40.0 |
ITC, isolated tumor cells; MAC, macrometastases; MIC, micrometastases; SLN, sentinel lymph node.